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Background: Despite decades of research, our knowledge of several important aspects of periodontal pathogenesis 
remains incomplete. Epigenetics allows to perform dynamic analysis of different variations in gene expression, 
providing this great advantage to the static measurement provided by genetic markers. The aim of this systematic 
review is to analyze the possible relationships between different epigenetic mechanisms and periodontal diseases, 
and to assess their potential use as biomarkers of periodontitis.   
Material and Methods: A systematic search was conducted in six databases using MeSH and non-MeSH terms. 
The review fulfilled PRISMA criteria (Preferred Reporting Items for Systematic reviews and Meta-analysis). 
Results: 36 studies met the inclusion criteria. Due to the heterogeneity of the articles, it was not possible to conduct 
quantitative analysis. Regarding qualitative synthesis, however, it was found that epigenetic mechanisms may be 
used as biological markers of periodontal disease, as their dynamism and molecular stability makes them a valu-
able diagnostic tool. 
Conclusions: Epigenetic markers alter gene expression, producing either silencing or over-expression of molecu-
lar transcription that respond to the demands of the cellular surroundings. Gingival crevicular fluid collection is 
a non-invasive and simple procedure, which makes it an ideal diagnostic medium for detection of both oral and 
systemic issues. Although further research is needed, this seems to be a promising field of research in the years 
to come.
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Introduction
Periodontitis is a multifactorial inflammatory disease 
in which bacterial stimulus, mainly anaerobic Gram-
negative bacteria, trigger molecular signaling, which in 
turn initiates an immune inflammatory response by the 
host, with the objective of halting or eliminating these 
microbial cells. Nevertheless, in some individuals this 
response intended to defend the organism can be dis-
proportionate, producing paradoxically tooth support-
ing structures loss (1).
When we talk about susceptibility to a disease, this 
unavoidably refers to genetic components. Mutations 
in certain genes, or gene expression disorders of those 
genes that encode pro-inflammatory proteins, can pro-
duce a hypersecretory genotype of inflammatory mol-
ecules, thus increasing the risk of disease. In this con-
text, numerous investigations have been conducted to 
find genetic variants that can be related to increased risk 
of periodontitis (2). It has been demonstrated in several 
studies that some genetic disorders can be associated 
to periodontitis. Nevertheless, not every individual with 
these disorders will necessarily develop periodontitis 
and conversely, not every patient with periodontal prob-
lems will present these genetic disorders (1, 2). 
Despite decades of periodontal research, it is still not 
clear why some individuals do not respond to periodon-
tal treatment adequately, or why the rate of progression 
of periodontal lesions varies among individuals.
Epigenetics is an emerging field of science that study 
the changes in gene expression, that do not require or 
involve changes in DNA sequencing. In other words, 
epigenetics is not directly related to gene mutation, but 
to disorders in the expression of certain genes that make 
it possible to adapt cell functions to cellular surround-
ing needs. This means that different situations that can 
occur in cell environment, such as inflammation, en-
vironmental changes etc, can lead to silencing or over-
expression of certain genes that express different mol-
ecules (3). 
This field of biology allows a dynamic analysis of gene 
expression variations, thus epigenetic markers provide 
considerable advantages to genetic static measurements 
(4). In addition, it may contribute to a better understand-
ing of the association between risk factors and peri-
odontal disease susceptibility.
There are three main mechanisms of epigenetic regula-
tion: DNA methylation, post-translational histone mod-
ification, and non-coding RNA. 
-DNA methylation 
DNA methylation is a process in which methyl groups 
are added to the 5’ end of Cytosine nucleobase (C). 
Methylated CpG dinucleotides are located in CpG-
rich regions, also called CpG islands, present in many 
gene promoter regions. Some transcriptional factors are 
only capable of interacting with non-methylated DNA 
sequences, so methylation can avoid this interaction. 
Therefore, hypermethylation leads to less transcription 
or even silencing of some genes. And on the other hand, 
a methylation defect or DNA hypomethylation is associ-
ated to gene transcription activation (5, 6). 
DNA methylation disorders are associated with genome 
instability, alterations in chromatin conformation, and 
chromosome fragility (7). These aberrant methylation 
statuses have been associated with oral cancer (7, 8) and 
with diverse inflammatory processes (9). DNA methyla-
tion is the most widely researched epigenetic mechanism. 
-Post-translational histone modifications
DNA is wrapped around proteins known as histones 
to form nucleosomes, which are the essential units of 
chromosome structures. Histones can undergo chemi-
cal modifications that will change chromatin status, and 
so gene expression. It has been demonstrated that these 
post-translational modifications (PTMs) are disturbed 
in a wide variety of diseases such as cancer, neurologi-
cal syndromes, or septic inflammation (10).
-Non-coding RNA or micro-RNA 
In all human genomes, only a small number of genes 
encode proteins. For many years, it was believed that 
some parts of DNA had no function and this was known 
as rubbish DNA. But later on it was shown that some of 
these genome regions could play an active role in gene 
transcription regulation in a wide variety of biological 
processes. These are non-coding RNAs or ncRNAs (11), 
which include micro-RNAs or miRNAs. 
MiRNAs are a large family of short non-coding RNAs 
(17-25 nucleotides). More than 1000 miRNAs have been 
identified in the human genome. MiRNAs are able to 
control or regulate  gene expression (12,13). Post-tran-
scriptional binding to complementary RNA sequences, 
normally to 3´ untranslated region (3´UTR), usually 
causes gene silencing or repression of translation and 
protein synthesis (4,11,12). Gene expression suppression 
only requires the attachment of six base pairs, and so 
a single miRNA can act simultaneously as a potential 
regulator of the expression of thousands of target genes, 
with notable impact on protein synthesis (13,14).
The high stability, sensitivity, specificity and dynamism 
of these epigenetic mechanisms make them an optimal 
source for the identification of candidate biomarkers for 
diagnosis of chronic infectious diseases(4).
Despite the substantial number of studies that have 
identified epigenetic disorders in different inflamma-
tory diseases, few have reported the possible relation-
ship between epigenetic changes and periodontitis. 
Moreover, no systematic review to date has analyzed 
comprehensively this relationship. 
The aim of this systematic review is to analyze the pos-
sible relationship between epigenetic mechanisms and 
periodontal diseases in humans, and to asses their po-
tential use as biomarkers for periodontitis. 
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Material and Methods 
A systematic literature search was conducted, fulfilling 
PRISMA criteria (Preferred Reporting Items for Sys-
tematic reviews and Meta-analyses). The review was 
registered in the PRISMA database (PROSPERO), ref-
erence number CRD42017063924. 
-Review question 
The PICO question (Population, Intervention/Exposure, 
Comparison, Outcome) was formulated as follows: 
Population – humans; Exposure – epigenetic disorders; 
Comparison – healthy subjects without periodontal dis-
ease; Result – periodontal disease. “Does a relationship 
exist in humans between epigenetic biomarker levels 
and periodontal disease?”
-Inclusion and exclusion criteria 
Inclusion criteria were as follows: observational stud-
ies of human populations, case-control studies, cohort 
studies, randomized clinical trials. Both prospective 
and retrospective studies were included. On the other 
hand, clinical case reports, literature reviews, editori-
als, animal studies, and studies involving in vitro ex-
periments were not included.
-Search strategy 
In order to identify all studies that would respond to the 
PICO question, a rigorous electronic research was con-
ducted in Pubmed, Embase, Scopus, Scielo, Web of Sci-
ence and Cochrane databases. No language filters were 
applied to avoid missing any potentially relevant article. 
The research was updated in April 2019.
The following MeSH and non-MeSH search terms were 
used in order to encompass every type of periodon-
tal disease and epigenetic mechanism: (“periodontal 
disease” OR periodontitis OR “periodontal infection” 
OR periodont*) AND (microRNAs OR microRNA OR 
“DNA methylation” OR “histone modification” OR epi-
genetics OR epigenomics OR “epigenetic biomarker” 
OR “epigenomic biomarker” OR epigen*). In addition, 
handsearching was also conducted to identify studies 
that were missed by the primary electronic search.
The selection process was carried out by two reviewers 
(PAP and MBC), who assessed the titles and abstracts 
of the articles found in the electronic databases. A Kap-
pa score was calculated to measure the degree of agree-
ment between both raters.
Furthermore, duplicated articles were identified and re-
moved. In case of any disagreement, a third reviewer 
was consulted (ALR). 
When the title and abstract did not provide enough in-
formation to decide whether or not to include an article, 
the reviewers read the full text thoroughly before taking 
a final decision.
After the first selection phase, full texts of the selected 
articles were read, and in case of further exclusions, 
reasons for rejection were registered.
-Data extraction and list of variables  
The following data was extracted from each of the in-
cluded studies: author, year of publication, study type, 
sample size, type of sample,  type of periodontal disease 
analyzed (chronic or aggressive periodontitis), type of 
epigenetic marker analyzed (DNA methylation, histone 
modification, microRNAs), results and quality of the 
studies. 
-Quality assessment 
Newcastle-Ottawa Quality Assessment Scale (NOS) 
was used to assess the quality of the selected articles. 
The scale consists of eight items dealing with specific 
aspects of methodological quality. Each study can be 
awarded only one point for each quality item, with the 
exception of comparability, which can be awarded two 
points, thus, the maximum possible score is nine points. 
The quality of the studies was assessed independently 
by both reviewers. Again, if any disagreement occurred 
for any article, consensus was reached by consulting a 
third reviewer.  
Results 
1. Study selection and PRISMA flow diagram 
During the initial electronic search, a total of 1863 ar-
ticles (448 in Pubmed, 631 in Embase, 363 in Scopus, 
415 in Web of Science, 3 in Scielo, 0 in Cochrane and 
3 in other sources) were found.. After eliminating du-
plicates, this total of 1863 was reduced to 879 articles. 
After screening the titles and abstracts, a further 808 
articles were discarded, mostly because they were not 
relevant to the review objectives (n=469), others be-
cause they were literature reviews (n=67), in vitro ex-
periments (n=142) or analyzed the relations between 
epigenetics and pathologies other than periodontal dis-
ease (n=130).
Seventy-one articles fulfilled the inclusion criteria 
listed above. After reading the full papers, a further 35 
articles were rejected. These were excluded for the fol-
lowing reasons: studies involving in vitro experiments 
(n=13); studies that did not analyze epigenetic mecha-
nisms (n=8); did not study relations with periodontal 
diseases (n=6); no control group (n=5), were literature 
reviews (n=1); animal studies (n=1); or a laboratory 
manual for sample analysis (n=1). 
Finally, 36 studies were included in the qualitative syn-
thesis. Inter-examiner agreement was high (0.9). PRIS-
MA flow diagram (Fig. 1) summarizes the study selec-
tion process. 
2. Characteristics of the studies included  
All 36 articles selected were case-control studies. Sam-
ple sizes varied between 6 and 290 subjects. Regarding 
the epigenetic mechanisms investigated, 20 papers ana-
lyzed DNA methylation, and 16 investigated miRNAs. 
The studies which analyzed post-translational histone 
modification were human-based in vitro experimenta-
tion, so were not included in this review. Table 1, 1 con-
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Table 1: Characteristics and outcomes of the reviewed studies.
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Table 1 continue: Characteristics and outcomes of the reviewed studies.
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Table 1 continue-1: Characteristics and outcomes of the reviewed studies.
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Table 1 continue-2: Characteristics and outcomes of the reviewed studies.
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Table 1 continue-3: Characteristics and outcomes of the reviewed studies.
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Table 1 continue-4: Characteristics and outcomes of the reviewed studies.
tinue, 1 continue-e, 1 continue-2, 1 continue-3, 1 con-
tinue-4 summarizes the characteristics of the included 
studies (Table 1, 1 continue, 1 continue-e, 1 continue-2, 
1 continue-3, 1 continue-4). 
3. Qualitative synthesis 
Author (year) Selection Comparability Exposure Total 
score
Bagavad et al., 
(20)
(2019)
* * * * * * * 7
Naqvi et al., 
(36)
(2019)
* * * * * * * 7
Yoneda et al., 
(21)
(2019)
* * * * * * 6
Micó et al., (4)
(2018)




* * * * * * * 7
Li et al.,(38) 
(2018)
* * * * * * 6
Ghotloo et al., 
(33)
(2018)
* * * * * * 6
Table 2: Quality of the reviewed studies according to Newcastle-Ottawa Scale.
MA: Mean Age; ND: No Data; CP: Chronic Periodontitis; AP: Aggressive periodontitis.; EG: Experimental gingivitis; PI: Periimplantitis; CPS: 
Chronic Periodontitis Smokers; CPNS: Chronic Periodontitis Non Smokers
According to the scores obtained by the Newcastle-
Ottawa scale for case-control studies, the quality of the 
studies was moderate to high (Table 2, 2 continue, 2 
continue-1). Table 1 summarizes the results of the re-
viewed studies.




* * * * * * 6
Asa´ad et al., 
(39)
(2017)
* * * * * * * * 8
Saito et al., (23)
(2017)
* * * * * * 6
Kojima et al., 
(31)
(2016)




* * * * * * * 7
Schulzet al. (7)
(2016)
* * * * * * * 7
Planello et al. 
(8)
(2016)




* * * * * * 6
Wang et al.,(19)
(2014)
* * * * * * 6
Ogata et al., 
(13)
(2014)




* * * * * * 6
de Souza et 
al.,(28)
(2014)
* * * * * * * 7
de Faria Amor-
mino et al.,(9) 
(2013)
* * * * * * 6
de Camargo et 
al.,(10)
(2013)
* * * * 4
Stefani et 
al.,(24) (2013)
* * * * * * 6
Zhang et al.,(30) 
(2013)
* * * * * * * 7
Table 2 continue: Quality of the reviewed studies according to Newcastle-Ottawa Scale.
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Kadkhodaza-
deh et al.,( 18)
(2013)
* * * * * * 6
Ishida et al., 
(25)
(2012)
* * * * * * * 7
Stoecklin-Was-
mer et al., (14)
(2012)
* * * * * * 6
Perri et al., (12)
(2012)
* * * * * * 6
Lee et al., (35) 
(2011)
* * * * * * 6
Viana et al., 
(27)
(2011)
* * * * * * 6
De Oliveira et 
al.,(32)
(2011)
* * * * * * 6
Xie et al.,(34) 
(2011)
* * * * * * * 7
Andia et al., (6)
(2010)
* * * * * * 6
Loo et al., (17) 
(2010)
* * * * * 4
Zhang et al., 
(40)
(2010a)
* * * * * 4
Zhang et al., 
(26)
(2010b)
* * * * * * 6
Oliveira et al., 
(16)
(2009)
* * * * * 5
Table 2 continue-1: Quality of the reviewed studies according to Newcastle-Ottawa Scale.
Criteria: (1) Adequate case definition. (2) Representativeness of the cases. (3) Selection of controls. (4) Definition of controls. (5) Comparability 
of cases and control on the basis of the design or analysis, (5a) for one factor and (5b) for additional factor. (6) Ascertainment of exposure. (7) 
Same method of ascertainment for cases and controls. (8) Non-response rate.
Discussion 
The present systematic review investigated the relation-
ship between epigenetic mechanisms and periodontal 
pathology in humans. The selected papers were thor-
oughly analyzed in order to distinguish epigenetic 
markers expression differences between periodontally 
affected tissue compared to healthy tissue, and to criti-
cally determine if these epigenetic markers can be con-
sidered as diagnostic or prognostic periodontal markers.
To reduce the risk of bias, the initial search was con-
ducted in six databases, complemented by a manual 
search in the reference sections of the articles found.
The data extracted from the studies derived mostly 
from human gingival biopsies. Baptista et al. (15), An-
dia et al. (6) and Oliveira et al. (16) obtained cells from 
mouth rinsing, while Loo et al. (17); Kadkhodazadeh et 
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al. (18); Wang et al. (19), Bagavad et al. (20) and Yoneda 
et al., (21)  used blood samples. And three studies obtain 
data from gingival crevicular fluid (4,22,23). 
In spite of the large amount of information about histo-
pathology, molecular biology and genetics involved in 
periodontal diseases, little research has analyzed epi-
genetic mechanisms in periodontitis. There is a large 
number of genes and gene promoter regions in the hu-
man genome, as well as non-coding genetic material. 
This means there is a considerable number of complex 
epigenetic markers interacting with each other and 
adapting dynamically to cellular functional demands. 
Futhermore, what hampered the comparison between re-
sults was that each study focused on a specific gene. This 
is why, it was not possible to perform a meta-analysis of 
the available data and come up with a single conclusion.
-DNA Methylation. 
Regarding DNA methylation, some works observed a 
hypomethylated state of the gene promoter region that 
encoded pro-inflammatory molecules such as interleu-
kin 8 (IL8) (6), IL6 (24, 25), IL10, IFNg (26,27) and 
CCL25, IL17 and Il13Ra1 (7). De Souza et al. (28) stud-
ied the methylation state in periodontal patients and 
found an overall hypomethylation of immune-inflam-
matory genes. This is associated with increased pro-
inflamatory response to periodontal pathogens, thus 
this hypomethylated state can lead to an exaggerated 
response to periodontal infections.   
Nevertheless, it has been suggested that once the in-
flammatory stimulus is perpetuated, it reaches a balance 
between bacterial challenge and immuno-inflammatory 
response (29). In this way, in advanced periodontal le-
sions, cytokines can be then downregulated due to hy-
permethylation of these immune-inflamatory genes. 
In this context, several studies have observed a hy-
permethylated state for the promoter region of COX2 
gene, E-Cadherina and TNFa in patients with chronic 
periodontitis (17, 30, 31). This hypermethylation leads to 
gene silencing, thus to less mRNA expression of proin-
flammatory cytokines such as PGE2 and TNFa, which 
are strongly related to periodontal pathology. This down-
regulation of this proinflammatory cytokines will pre-
vent further attachment loss (29). This concur with the 
findings obtained by Loo et al. (17) and Zhang et al. (30) 
and Kojima et al. (31) who observed hypermethylation of 
these genes, which will silence or reduce inflammatory 
cytokine expression. De Oliveira et al. (32) and De Faria 
Amormino et al. (9) also observed this state of hyper-
methylation in inflammatory signaling cascades and an 
important attachment site for NF-kb activation, a potent 
initiator of bone loss.  Once more, this initial hyperin-
flammatory phase will be balanced by hypermethylation.
-Micro-RNA.
It was also difficult to compare articles which analyzed 
non-coding RNAs, such as micro-RNAs or mirRNAs, 
in periodontitis. The vast majority of these studies fo-
cused on identifying the most relevant miRNAs which 
were over-expressed and under-expressed, in healthy 
and periodontitis-affected gingival tissue. Therefore, 
these miRNAs could play an important role in regulat-
ing inflammatory response. In addition, many of these 
papers also aimed to search for miRNA target genes. 
Among these, miRNA146 stand out. This miRNA, in 
response to bacterial stimulus, seem to negatively regu-
late TLR signaling (20).
The up-regulation of this miRNA has been associated 
to a decreasing number of cytokines such as TNFa and 
IL-B, as well as NF-kb; for this reason, it seems rea-
sonable to think that they can contribute on avoiding 
excessive tissue damage caused by a disproportionate 
response (22,33).
MiRNA146a has also been associated with low levels 
of EGF and TGFb, which reduce regeneration poten-
tial and could be related to unsatisfactory responses to 
treatment (11).
After analyzing all the studies included in the present 
review, there were 6 papers which only analyzed miR-
NA146a without comparing it with other miRNAs (11, 
18, 20, 22, 33, 34). When miRNA146a increases, TNF, 
IL1b and IL6 will decrease. This will change RANK/
RANKL/OPG ratio in favor of osteoclastogenesis. Kad-
khodazadeh et al.(18) observed that miRNA146a and 
miRNA499 levels were high in periodontally-affected 
tissues, thus increasing the effects of proinflammatory 
cytokines RANK and MMP, in periodontal diseases. 
High miRNA146 levels seem to lead to NF-kb activa-
tion, a transcription factor strongly associated with pro-
inflammatory molecules release (18).
In agreement with these findings, Motedayyen et al. (11) 
found 32.6 times higher levels of this miRNA in tissues 
presenting periodontal pathology, than that of healthy 
subjects, obtaining a positive association between this 
and increased probing depth and clinical attachment 
levels. Moreover, the same study also found lower levels 
of TNFa and IL6 when miRNA146a levels increased.
miRNA146a and miRNA499 have a major impact on 
the interferon and interleukin pathways, which play an 
important role in periodontal pathogenesis. Both were 
significantly upregulated in periodontally affected tis-
sue (18). On the other hand, miRNA155 was reduced 
in patients with chronic periodontitis. This miRNA is 
also related to the activation of TLR and IL receptors, 
so they may have similar functions to miRNA146. miR-
NA301a is the most powerful repressor of NF-kb. It has 
been suggested that bacterial lipopolysaccharides (LPS) 
stimulus and chronic host inflammatory response caus-
ing cytokine release, may over-express miRNA301a, 
leading to NF-kb activation (35). 
miRNA203 is important for inducing differentiation and 
repressing cell proliferation. It has been demonstrated 
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that in periodontally-affected tissues, in which there is a 
high cell turnover in the junctional epithelium and con-
nective tissue, miRNA203 levels are reduced in compari-
son with healthy tissue, an observation that concurs with 
their known function (14). Besides, miRNA30e modu-
lates connective tissue metabolism and inflammation. 
miRNA103, miRNA22 and miRNA106b present some 
target genes also related to inflammation and bone me-
tabolism (ILs, PGE2, TNF, etc.). These miRNAs were 
upregulated in periodontally affected tissues (12,14).
Other miRNAs (miRNA150 and miRNA200b) have 
been related to cancer, inflammatory processes, autoim-
mune diseases and other physiological and pathological 
processes (13). The present results suggest that there is 
a network regulating cell cycle and immune and inflam-
matory cell movement in tissues. These miRNAs have 
also been found to be upregulated in periodontally-af-
fected tissue (13). 
Only three studies have found miRNAs in gingival cre-
vicular fluid, published in 2017 and 2018. 
Radovic et al., (22) and Saito et al., (23) found miRNAs 
overexpression in gingival crevicular fluid of patients 
with chronic periodontitis. They found over-expression 
of miRNA146a and miRNA155 in diabetic and non-
diabetic patients with chronic periodontitis at baseline, 
however, these miRNA levels reduced six weeks after 
non-surgical treatment, regardless of whether or not they 
were diabetic (22). In addition, miRNA146a expression 
levels were higher in diabetic patients with periodonti-
tis than patients with periodontitis alone. The study’s 
multivariable analysis revealed that miRNA146a and 
miRNA155 levels were significantly associated with 
periodontitis after adjustment for age and gender (22). 
The third study was published by the same research 
group of the present study, which also found miRNAs 
in gingival crevicular fluid (4). Six miRNAs (miR671, 
miR122, miR1306, miR27a, miR223, miR1226) were 
identified, but only miR1226 showed statistically signif-
icant differences(4). In spite of the small sample size (9 
patients with periodontitis and 9 healthy controls), this 
preliminary study confirmed the possibility of isolating 
miRNAs from gingival crevicular fluid and thoroughly 
explained the purification process of miRNAs from this 
transudate (4). Therefore, gingival crevicular fluid col-
lection is a non-invasive and simple procedure, and can 
be especially useful for identifying people at risk for 
initiation or progression of periodontitis and for moni-
toring the response to periodontal therapy.
Both epigenetic mechanisms seem to either increase or 
decrease, so these observations varied between studies. 
The transcription regulation of some genes prevents 
the inflammatory process from becoming decisive and 
brings about a metastable balance between inflamma-
tion and stimulus. As mentioned earlier, both analyzed 
mechanisms have been associated to genes that are re-
lated to synthesis and activation of NF-kb, interleukins, 
TNFa, IFNg etc. This makes these epigenetic markers 
possible diagnostic, prognostic markers, and even ther-
apeutic agents, for the management of inflammatory 
diseases. Well-designed randomized clinical trials are 
needed to assess the usefulness of these markers.  
One criteria that limited the number of studies reviewed 
in the present systematic review was, not including in 
vitro studies. When the implication of a factor within a 
complex multifactorial interaction network is being stud-
ied, in vitro studies are not adequate to assess the effect 
of that factor. This is to say, a single ncRNA may affect 
the transcription of a large number of genes, and at the 
same time, the greater or lesser expression of many oth-
ers (13,14). For this reason, it was decided to focus the 
review on studies conducted in human tissues presenting 
periodontal pathology, excluding in vitro studies.  
Despite the quality assessment of the observational 
case-control studies analyzed in the present review re-
vealed that they were all medium-high quality, other 
limitation was the heterogeneity of the epigenetic mech-
anisms they studied. Future studies should focus on 
those mechanisms that have shown stronger association 
with periodontitis. Furthermore, given the changing in-
flammatory status in patients with periodontal disease, 
studies should select patients with active untreated peri-
odontitis, as once the disease has been treated or sta-
bilized, the mechanisms of gene expression regulation 
may be altered. Due to methodological heterogeneity 
of the articles and differences in the epigenetic mecha-
nisms studied, it was not possible to conduct quantita-
tive analysis or to reach firm conclusions.
Nevertheless, it may be concluded that epigenetic 
mechanisms play an important role in regulating the 
expression of genes related to inflammatory processes. 
In periodontitis, the results of the reviewed articles, 
point to both the silencing of gene expression and over-
expression of transcription mediated by epigenetic 
mechanisms. In most of the reviewed articles, signifi-
cant differences were found in biomarker levels in peri-
odontally-affected tissues compared to healthy tissues. 
Epigenetic mechanisms seem to allow adaptation to 
chronic inflammatory stimulus, thus, in first place, they 
can permit over-expression of a specific gene, but when 
the inflammatory process becomes chronic, they can si-
lence it, in order to establish a metastable balance that 
prevent an excessive periodontal destruction.
Epigenetic mechanisms have proved to be reliable bio-
markers for diagnosing inflammatory processes due to 
their dynamism and molecular stability. It is important 
to use other less invasive sources, different to gingival 
biopsies, such as gingival crevicular fluid. Epigenetic 
biomarkers can provide a better understanding of peri-
odontal pathogenesis and a reliable tool for clinicians to 
identify susceptible patients to periodontitis.
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